Inflammatory Marker Predicts Liver Cancer Risk in T2D

TOPLINE: In patients with newly diagnosed type 2 diabetes (T2D), elevated YKL-40 (chitinase-3–like protein 1) levels were strongly linked to an increased risk for liver cancer and, to a lesser extent, bladder cancer, highlighting the potential of YKL-40 as a biomarker for obesity-related and gastrointestinal cancers…